STOCK TITAN

Concord Medical Files 2023 Annual Report on Form 20-F

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Concord Medical Services Holdings (NYSE: CCM) filed its 2023 Annual Report on Form 20-F, showcasing its performance in cancer treatment, research, education, and prevention in China. Shareholders can access the report electronically or request a hard copy for free.
Concord Medical Services Holdings (NYSE: CCM) ha presentato il suo Rapporto Annuale 2023 sul Modulo 20-F, evidenziando le sue prestazioni nel trattamento, nella ricerca, nell'educazione e nella prevenzione del cancro in Cina. Gli azionisti possono accedere al rapporto elettronicamente o richiedere una copia cartacea gratuitamente.
Concord Medical Services Holdings (NYSE: CCM) ha presentado su Informe Anual 2023 en el Formulario 20-F, mostrando su desempeño en el tratamiento, investigación, educación y prevención del cáncer en China. Los accionistas pueden acceder al informe electrónicamente o solicitar una copia impresa de forma gratuita.
콩코드 메디컬 서비스 홀딩스 (NYSE: CCM)는 2023년 연차 보고서(20-F 양식)를 제출하여 중국에서 암 치료, 연구, 교육, 예방 분야의 성과를 소개했습니다. 주주들은 이 보고서를 전자적으로 접근하거나 무료로 하드 카피를 요청할 수 있습니다.
Concord Medical Services Holdings (NYSE: CCM) a déposé son rapport annuel 2023 sur le formulaire 20-F, mettant en avant ses performances dans le traitement, la recherche, l'éducation et la prévention du cancer en Chine. Les actionnaires peuvent accéder au rapport électroniquement ou demander une copie papier gratuitement.
Concord Medical Services Holdings (NYSE: CCM) hat seinen Jahresbericht 2023 auf Formular 20-F eingereicht, der seine Leistungen in den Bereichen Krebsbehandlung, -forschung, -bildung und -prävention in China darstellt. Aktionäre können den Bericht elektronisch einsehen oder kostenlos eine gedruckte Kopie anfordern.
Positive
  • None.
Negative
  • None.

BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to http://ir.ccm.cn.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Cision View original content:https://www.prnewswire.com/news-releases/concord-medical-files-2023-annual-report-on-form-20-f-302122062.html

SOURCE Concord Medical Services Holdings Limited

FAQ

What type of company is Concord Medical Services Holdings ?

Concord Medical Services Holdings is a healthcare provider specialized in cancer treatment, research, education, and prevention in China.

When did Concord Medical file its 2023 Annual Report?

Concord Medical filed its 2023 Annual Report on Form 20-F for the fiscal year ended December 31, 2023.

Where can shareholders access Concord Medical's Annual Report electronically?

Shareholders can access Concord Medical's Annual Report electronically on the company's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.

How can shareholders request a hard copy of Concord Medical's Annual Report?

Shareholders can request a hard copy of Concord Medical's Annual Report free of charge by submitting a request to http://ir.ccm.cn.

Concord Medical Services Holding Limited

NYSE:CCM

CCM Rankings

CCM Latest News

CCM Stock Data

34.27M
84.46M
18%
0.29%
0.26%
Medical Care Facilities
Healthcare
Link
United States of America
Beijing